CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-26 | WEN LEANA Director | Grant or award · Stock Option (right ot buy) | +10,000 | 10,000 | ||
| 2025-08-26 | WEN LEANA Director | Grant or award · Restricted Stock Unit | +8,000 | 8,000 | ||
| 2025-08-26 | Belldegrun Arie Director | Grant or award · Stock Option (right ot buy) | +20,000 | 20,000 | ||
| 2025-08-11 | Schoenberg Mark Chief Medical Officer | Sale | −10,000 | $17.69 | $177K | 148,229 |
| 2025-07-28 | Barrett Elizabeth A. Chief Executive Officer | Grant or award · Performance Stock Units | +87,615 | 87,615 | ||
| 2025-07-28 | Smith Jason Drew General Counsel | Option exercise | +16,500 | 49,014 | ||
| 2025-07-28 | Smith Jason Drew General Counsel | Sale | −7,522 | $19.14 | $144K | 41,492 |
| 2025-07-28 | Schoenberg Mark Chief Medical Officer | Option exercise | +10,000 | 163,378 | ||
| 2025-07-28 | Schoenberg Mark Chief Medical Officer | Sale | −5,149 | $19.14 | $99K | 158,229 |
| 2025-06-09 | Schoenberg Mark Chief Medical Officer | Sale | −5,162 | $7.37 | $38K | 153,378 |
| 2025-06-08 | Schoenberg Mark Chief Medical Officer | Option exercise | +10,000 | 158,540 | ||
| 2025-06-08 | Schoenberg Mark Chief Medical Officer | Option exercise · Restricted Stock Units | −10,000 | 10,000 | ||
| 2025-02-26 | Robinson James A. Jr. Director | Option exercise | +2,000 | 4,000 | ||
| 2025-02-26 | Robinson James A. Jr. Director | Option exercise · Restricted Stock Unit | −2,000 | 4,000 | ||
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +1,334 | 146,425 | ||
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −759 | $11.14 | $8K | 145,666 |
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +3,333 | 148,999 | ||
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −1,896 | $11.14 | $21K | 147,103 |
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Option exercise | +3,333 | 150,436 | ||
| 2025-01-31 | Schoenberg Mark Chief Medical Officer | Sale | −1,896 | $11.14 | $21K | 148,540 |
Page 5 of 13 · 244 trades